Jane Street Group, LLC Amicus Therapeutics, Inc. Transaction History

Jane Street Group, LLC

  • $88.2 Billion
  • Q2 2024

A detailed history of Jane Street Group, LLC transactions in Amicus Therapeutics, Inc. stock. As of the latest transaction made, Jane Street Group, LLC holds 632,266 shares of FOLD stock, worth $6.9 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
632,266
Previous 147,367 329.04%
Holding current value
$6.9 Million
Previous $1.74 Million 261.5%
% of portfolio
0.01%
Previous 0.0%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024
BUY
$9.04 - $11.75 $4.38 Million - $5.7 Million
484,899 Added 329.04%
632,266 $6.27 Million
Q1 2024

May 15, 2024
SELL
$11.43 - $14.24 $1.31 Million - $1.64 Million
-114,966 Reduced 43.82%
147,367 $1.74 Million
Q4 2023

Feb 14, 2024
BUY
$9.97 - $14.52 $1.29 Million - $1.88 Million
129,730 Added 97.83%
262,333 $3.72 Million
Q3 2023

Nov 14, 2023
BUY
$11.78 - $13.86 $101,308 - $119,196
8,600 Added 6.94%
132,603 $1.61 Million
Q2 2023

Aug 14, 2023
BUY
$10.72 - $13.3 $200,088 - $248,244
18,665 Added 17.72%
124,003 $1.56 Million
Q1 2023

May 15, 2023
BUY
$10.91 - $13.54 $399,404 - $495,685
36,609 Added 53.27%
105,338 $1.17 Million
Q4 2022

Feb 14, 2023
BUY
$9.89 - $12.7 $466,016 - $598,424
47,120 Added 218.06%
68,729 $839,000
Q3 2022

Nov 14, 2022
SELL
$9.82 - $12.75 $379,994 - $493,374
-38,696 Reduced 64.17%
21,609 $225,000
Q3 2022

Nov 14, 2022
SELL
$9.82 - $12.75 $379,994 - $493,374
-38,696 Reduced 64.17%
21,609 $225,000
Q2 2022

Aug 16, 2022
SELL
$6.23 - $11.12 $164,091 - $292,889
-26,339 Reduced 30.4%
60,305 $647,000
Q1 2022

May 17, 2022
BUY
$7.89 - $12.48 $131,202 - $207,529
16,629 Added 23.75%
86,644 $821,000
Q4 2021

Feb 15, 2022
SELL
$9.82 - $12.44 $648,178 - $821,114
-66,006 Reduced 48.53%
70,015 $808,000
Q3 2021

Nov 16, 2021
BUY
$8.74 - $11.84 $24,786 - $33,578
2,836 Added 2.13%
136,021 $1.3 Million
Q2 2021

Aug 16, 2021
BUY
$8.71 - $10.72 $148,270 - $182,486
17,023 Added 14.65%
133,185 $1.28 Million
Q1 2021

May 18, 2021
SELL
$9.2 - $23.86 $46,082 - $119,514
-5,009 Reduced 4.13%
116,162 $1.15 Million
Q4 2020

Feb 17, 2021
BUY
$13.47 - $24.89 $469,402 - $867,366
34,848 Added 40.37%
121,171 $2.8 Million
Q3 2020

Nov 17, 2020
BUY
$12.89 - $15.89 $957,688 - $1.18 Million
74,297 Added 617.8%
86,323 $1.22 Million
Q2 2020

Aug 17, 2020
SELL
$8.86 - $15.69 $951,652 - $1.69 Million
-107,410 Reduced 89.93%
12,026 $181,000
Q1 2020

May 15, 2020
BUY
$6.63 - $11.16 $267,427 - $450,149
40,336 Added 50.99%
119,436 $1.1 Million
Q4 2019

Feb 14, 2020
BUY
$7.48 - $10.75 $591,668 - $850,325
79,100 New
79,100 $770,000
Q3 2019

Nov 14, 2019
SELL
$8.02 - $13.25 $345,485 - $570,783
-43,078 Closed
0 $0
Q2 2019

Aug 15, 2019
BUY
$10.96 - $14.4 $63,699 - $83,692
5,812 Added 15.6%
43,078 $538,000
Q1 2019

May 16, 2019
BUY
$10.04 - $13.92 $2,329 - $3,229
232 Added 0.63%
37,266 $507,000
Q4 2018

Feb 15, 2019
SELL
$8.38 - $13.44 $241,436 - $387,219
-28,811 Reduced 43.76%
37,034 $355,000
Q3 2018

Nov 14, 2018
BUY
$11.6 - $16.54 $299,256 - $426,698
25,798 Added 64.42%
65,845 $796,000
Q2 2018

Aug 15, 2018
SELL
$13.13 - $17.09 $893,772 - $1.16 Million
-68,071 Reduced 62.96%
40,047 $626,000
Q1 2018

May 15, 2018
BUY
$13.76 - $17.12 $697,122 - $867,350
50,663 Added 88.18%
108,118 $1.63 Million
Q4 2017

Feb 15, 2018
SELL
$12.51 - $16.24 $287,129 - $372,740
-22,952 Reduced 28.54%
57,455 $827,000
Q3 2017

Nov 14, 2017
BUY
$11.74 - $15.78 $943,978 - $1.27 Million
80,407
80,407 $1.21 Million

Others Institutions Holding FOLD

# of Institutions
278
Shares Held
324M
Call Options Held
260K
Put Options Held
261K
View Full List

About AMICUS THERAPEUTICS, INC.

FOLD Quotes by TradingView
  • Ticker FOLD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 280,497,984
  • Market Cap $3.06B
  • Description
  • Amicus Therapeutics, Inc., a biotechnology company, focuses on discovering, developing, and delivering medicines for rare diseases. Its commercial product and product candidates include Galafold, an oral precision medicine for the treatment of adults with a confirmed diagnosis of Fabry disease and an amenable galactosidase alpha gene variant bas...
More about FOLD
Track This Portfolio

Track Jane Street Group, LLC Portfolio

Follow Jane Street Group, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jane Street Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Jane Street Group, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email